Hepatic steatosis in potential liver donor candidates has important implications towards outcomes of liver transplant recipients and donor safety. Hepatic steatosis in potential donors in excess of established but varying institutional thresholds are considered as grounds for donor ineligibility. However, negiblible/absent hepatic steatosis (<5%) is considered acceptable universally. Currently Liver biopsy is regarded as reference standard. We show in our study that MR-PDFF has very high NPV for excluding significant hepatic steatosis (>10%). Thus MRI-PDFF can be utilized for liver donor screening and obviates the need for liver biopsy when MRI-PDFF values are <5%
This abstract and the presentation materials are available to members only; a login is required.